Chheki Sherpa, M.D.

45% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

1,453 Medicare Part D claims for 256 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 41% of claims.

Most prescribed

1. Levothyroxine Sodium382 claims
2. Synthroid164 claims
3. Methimazole115 claims
4. Trulicity60 claims
5. Hydrocortisone56 claims
6. Lantus Solostar50 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 81.2 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

2 hospitals and group practices

1. Reading HospitalWyomissing, PA · Acute Care Hospitals4 of 5 stars
2. Tower Health Medical GroupWyomissing, PA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.